Skip to main content

​SEC charges two former Ariad executives with insider trading

The allegations stem from the Cambridge biotech's discussions with the FDA in 2012 and 2013 regarding cancer drug Iclusig.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.